Alexei Mlodinow

Alexei is responsible for expanding and solidifying the medical affairs function at SIA, including management of the preclinical and clinical evidence pipeline, publication planning and key opinion leader (KOL) partnership. He co-founded SIA whilst studying in a joint MD-MBA program at Northwestern’s Kellogg School of Management and Feinberg School of Medicine. Prior to that, he graduated at the top of a +5,000-person class from the University of California, Santa Barbara, with dual degrees in Economics and Japanese. Alexei has authored over 20 peer-reviewed publications and book chapters, holds multiple issued patents, and regularly lectures on both science and entrepreneurship at national and international meetings. Alexei was also named one of Forbes’ “30 under 30” in 2018 and Crain’s “20 in their 20s” in 2019.